NOTO Mai

写真a

Affiliation

Hospital  Dermatology 

To the head of this page.▲

Research Interests 【 display / non-display 】

  • 皮膚科学

To the head of this page.▲

Graduating School 【 display / non-display 】

  • 　
    -
    2006.03

    Akita University   Faculty of Medicine   Graduated

To the head of this page.▲

Graduate School 【 display / non-display 】

  • 　
    -
    2014.03

    Akita University  Graduate School, Division of Medicine  Doctor's Course  Completed

To the head of this page.▲

Campus Career 【 display / non-display 】

  • 2017.10
    -
    Now

    Akita University   Hospital   Dermatology   Assistant Professor  

To the head of this page.▲
 

Thesis for a degree 【 display / non-display 】

  • Conserved expression of SOX13 orthologs in early vertebrate development．

    Noto M，Hasunuma N，Osada S and Manabe M 

    Akita Journal of Medicine  40   143 - 145   2013.09

    Domestic Co-author

To the head of this page.▲

Research Achievements 【 display / non-display 】

    ◆Original paper【 display / non-display 】

  • Sox13 is a novel early marker for hair follicle development

    Noto M，Noguchi N，Ishimura A，Kiyonari H，Abe T，Suzuki T，Hasunuma N，Taira M，Manabe M，Osada SI

    Biochemical and Biophysical Research Communications     2019.01  [Refereed]

    Research paper (journal)   Domestic Co-author

    • To the head of this page.▲

    ◆Other【 display / non-display 】

  • Moisturizing Effect of Emulsion Containing Partially Myristoylated Carboxylmethyl-chitosan Applied to Dry Skin

    Yokoi Aya, Manabe Motomu, Noto Mai, Hasunuma Naoko, Nozawa Kazumi, Kawaguchi Naoko, Seino Haruyoshi, Okuda Makoto, Yoshida Yasuhiro

    Hifu no kagaku ( Meeting of Osaka Dermatological Association/Meeting of Keiji Dermatological Association )  17 ( 6 ) 347 - 353   2018

    <p>We evaluated the efcacy and safety of an oil-in-water (O/W)-type emulsion containing partially myristoylated carboxymethyl-chitosan (PMCMC) in 19 patients with xerosis coexisting with itching following four weeks of application on dry skin and the itchy area. Dermatological ndings, water content of the stratum corneum, transepidermal water loss, and itching severity signicantly improved after four weeks of emulsion application. These results were consistent with those obtained using a heparinoid pharmaceutical water-in-oil (W/O)-type preparation. The patients lled in a questionnaire regarding self-reported results after using a product containing PMCMC ; they reported that their skin felt better after using a PMCMC emulsion (O/W) than after using a heparinoid pharmaceutical preparation (W/O). This study showed that an O/W type emulsion containing PMCMC could be useful to improve the condition of not only dry skin and itching, but also quality of life in patients with xerosis. <i>Skin Research, 17 : 347</i>-<i>353, </i><i>2018 </i></p>

    DOI

To the head of this page.▲